Heights Capital Management, Inc Biomea Fusion, Inc. Transaction History
Heights Capital Management, Inc
- $375 Billion
- Q2 2025
A detailed history of Heights Capital Management, Inc transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Heights Capital Management, Inc holds 3,839,349 shares of BMEA stock, worth $6.33 Million. This represents 1.84% of its overall portfolio holdings.
Number of Shares
3,839,349Holding current value
$6.33 Million% of portfolio
1.84%Shares
1 transactions
Others Institutions Holding BMEA
# of Institutions
98Shares Held
22.5MCall Options Held
1.12MPut Options Held
371K-
Cormorant Asset Management, LP Boston, MA3.57MShares$5.89 Million0.65% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.87 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$3.38 Million1.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$3.1 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA1.74MShares$2.88 Million0.02% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $48.3M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...